Advertisements



EU Considers Emergency Approvals To Boost COVID-19 Vaccine Rollout: Reuters

The European Commission is considering emergency approvals for CO read more.....»»

Category: blogSource: benzingaMar 3rd, 2021

Can I Be Required to Get Vaccinated Against Covid-19?

The U.S. Covid-19 vaccine rollout reached another milestone in early May when Pfizer Inc. and BioNTech SE, makers of the first inoculation authorized for emergency use in the country, asked for full regulatory approval. Such a designation for .....»»

Category: topSource: washpostMay 21st, 2021

: Fauci says U.S. may not even need AstraZeneca’s COVID-19 vaccine: report

AstraZeneca PLC's COVID-19 vaccine, which has been plagued by problems with its rollout, may not even be needed in the U.S., Dr. Anthony Fauci told Reuters......»»

Category: topSource: marketwatchApr 1st, 2021

State widens Covid vaccine eligibility, announces public-private partnership to boost distribution

Gov. Jay Inslee announced Monday a public-private partnership to move the state's Covid-19 vaccination efforts forward, effective immediately. The state has moved to the next phase of its rollout, Phase 1B. The first tier of Phase 1B will now extend.....»»

Category: topSource: bizjournalsJan 18th, 2021

An employer’s dilemma: to mandate (or not) the Covid-19 vaccine?

During a year in need of some brightness, December brought some great news: after emergency Food and Drug Administration approvals, first Pfizer and then Moderna shipped Covid-19 vaccines to locations throughout the United States, kicking off a ma.....»»

Category: topSource: bizjournalsJan 11th, 2021

Johnson & Johnson surges 9% after saying its coronavirus vaccine will begin human testing by September (JNJ)

Reuters Johnson & Johnson announced Monday that it identified a lead COVID-19 vaccine candidate that could begin human trials in September and be ready for emergency authorization use in 2021.  Shares of the healthcare com.....»»

Category: topSource: businessinsiderMar 30th, 2020

An Ohio state representative is trying to block the state"s $5 million vaccine lottery

Ohio Rep. Jena Powell told CNN's "New Day" on Monday that the COVID-19 vaccine lottery is a "gross misuse of taxpayer dollars." Dado Ruvic/Reuters An Ohio state lawmaker says she'll try to block the state's vaccine lottery.....»»

Category: dealsSource: nytMay 24th, 2021

Pfizer Hits Deadlock With India Over Vaccine Indemnity Issue: Reuters

Pfizer Inc (NYSE: PFE) and the Indian government are at loggerheads over a demand by the company for legal protection from any claims linked to the use of its COVID-19 vaccine, said read more.....»»

Category: blogSource: benzingaMay 21st, 2021

AstraZeneca"s COVID vaccine Vaxzevria authorized for emergency use in Japan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 21st, 2021

A pediatric infectious disease expert answers 7 common questions about children getting the COVID-19 vaccine

The FDA expanded emergency use of the Pfizer-BioNTech vaccine to children aged 12 to 15 on May 10, and so far no severe reactions have been reported. Charles Muro, age 13, celebrates being ino.....»»

Category: topSource: businessinsiderMay 19th, 2021

G20 Countries Water Down US Push For COVID-19 IP Waiver: Reuters

G20, a global forum representing the world’s largest economies, has come forward supporting “voluntary licensing” of COVID-19 vaccine patents, the draft conclusions of a summit shows. read more.....»»

Category: blogSource: benzingaMay 18th, 2021

: Swimsuits and luggage are hot items as U.S. shoppers prepare for summer events with relaxed COVID restrictions

Retailers are highlighting the categories that are on the upswing as the vaccine rollout continues and stimulus cash drives sales......»»

Category: topSource: marketwatchMay 18th, 2021

Japan’s economy slumps back into decline as COVID-19 hits spending

Japan’s economy shrank more than expected in the first quarter as a slow vaccine rollout and new COVID-19 infections hit spending on items such as dining out and clothes, raising concerns the country will lag others emerging from the pandemic......»»

Category: topSource: foxnewsMay 18th, 2021

Competing for tech talent? Give people the chance to change the world while advancing their careers

The talent crisis is poised for a comeback. The economic consequences of Covid-19 wiped out previously low unemployment rates in 2020, making it an employer’s market for many industries. As the vaccine rollout continues and the economy r.....»»

Category: topSource: bizjournalsMay 14th, 2021

European Union Announce Second Lawsuit Against AstraZeneca Over Delayed COVID-19 Vaccine Supply: Reuters

read more.....»»

Category: blogSource: benzingaMay 11th, 2021

Novavax extends 2-day loss to 31% as the biotech firm delays seeking emergency authorization for its COVID-19 vaccine

"We know that we are delaye.....»»

Category: smallbizSource: nytMay 11th, 2021

The NHS is launching a "vaccine passport" on its app for international travel

Downing Street said the NHS app's COVID-19 "vaccine passport" tool would be ready on Monday, when the UK's ban on international travel is lifted. Dado Ruvic/Reuters The UK's National Health Service app will be available on Monday to use.....»»

Category: personnelSource: nytMay 11th, 2021

Pfizer-BioNTech COVID-19 Vaccine Gets FDA Emergency Approval For Age Group 12-15

The U.S. Food and Drug Administration on Monday approved the emergency use of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine in adolescents aged between 12 to 15 years. read more.....»»

Category: blogSource: benzingaMay 11th, 2021

FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15

The U.S. Food and Drug Administration late Monday authorized the emergency use of Pfizer Inc. and BioNTech SE COVID-19 vacccine for children between the age.....»»

Category: topSource: marketwatchMay 10th, 2021

Why Novavax Shares Are Trading Lower Today

Novavax (NASDAQ: NVAX) shares are trading lower amid reports competing COVID-19 vaccines may be approved in Europe. The stock also dipped on reports the company is unlikely to seek emergency use authorization for its COVID-19 vaccine until June. read more.....»»

Category: blogSource: benzingaMay 10th, 2021

Eli Lilly to boost supply of Covid treatment in India, Reuters reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2021